Targeting plasminogen activator inhibitor-1 in tetracycline-induced pleural injury in rabbits. (Q50241255)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28860148 AND SRC:MED&resulttype=core&format=json

28 March 2020

title

Targeting plasminogen activator inhibitor-1 in tetracycline-induced pleural injury in rabbits (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28860148 AND SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28860148 AND SRC:MED&resulttype=core&format=json

28 March 2020

Douglas Cines

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28860148 AND SRC:MED&resulttype=core&format=json

28 March 2020

1

Galina Florova

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28860148 AND SRC:MED&resulttype=core&format=json

28 March 2020

8

Steven Idell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28860148 AND SRC:MED&resulttype=core&format=json

28 March 2020

9

Andrey A Komissarov

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28860148 AND SRC:MED&resulttype=core&format=json

28 March 2020

author name string

Ali O Azghani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28860148 AND SRC:MED&resulttype=core&format=json

28 March 2020

Sophia Karandashova

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28860148 AND SRC:MED&resulttype=core&format=json

28 March 2020

Chris Schaefer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28860148 AND SRC:MED&resulttype=core&format=json

28 March 2020

Serge V Yarovoi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28860148 AND SRC:MED&resulttype=core&format=json

28 March 2020

publication date

31 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28860148 AND SRC:MED&resulttype=core&format=json

American Journal of Physiology - Lung Cellular and Molecular Physiology

28 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28860148 AND SRC:MED&resulttype=core&format=json

28 March 2020

volume

314

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28860148 AND SRC:MED&resulttype=core&format=json

28 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28860148 AND SRC:MED&resulttype=core&format=json

28 March 2020

page(s)

L54-L68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28860148 AND SRC:MED&resulttype=core&format=json

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise th

28 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Novel plasminogen activator inhibitor-1-derived peptide protects against impairment of cerebrovasodilation after photothrombosis through inhibition of JNK MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

PAI-1-derived peptide EEIIMD prevents impairment of cerebrovasodilation by augmenting p38 MAPK upregulation after cerebral hypoxia/ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Use of urokinase in childhood pleural empyema

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Medical management of parapneumonic pleural disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Parapneumonic empyema deaths during past century, Utah.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

The distal hinge of the reactive site loop and its proximity: a target to modulate plasminogen activator inhibitor-1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

The increasing incidence of empyema

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

The spectrum of pneumococcal empyema in adults in the early 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

The P6−P2 Region of Serpins Is Critical for Proteinase Inhibition and Complex Stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Counterpoint: should fibrinolytics be routinely administered intrapleurally for management of a complicated parapneumonic effusion? No

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Directing sequence-specific proteolysis to new targets. The influence of loop size and target sequence on selective proteolysis by tissue-type plasminogen activator and urokinase-type plasminogen activator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

New therapeutic approaches to pleural infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Three decades of research on plasminogen activator inhibitor-1: a multifaceted serpin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Subtle structural differences between human and mouse PAI-1 reveal the basis for biochemical differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Kinetic studies on the interaction of streptokinase and other plasminogen activators with plasminogen and fibrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Targeting of plasminogen activator inhibitor 1 improves fibrinolytic therapy for tetracycline-induced pleural injury in rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Remarkable stabilization of plasminogen activator inhibitor 1 in a "molecular sandwich" complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

A specific plasminogen activator inhibitor-1 antagonist derived from inactivated urokinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Emergence of parapneumonic empyema in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

The pathogenesis of pleural space loculation and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Intrapleural low-molecular-weight urokinase or tissue plasminogen activator versus single-chain urokinase in tetracycline-induced pleural loculation in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Abnormalities of pathways of fibrin turnover in the human pleural space

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Single-chain urokinase alone or complexed to its receptor in tetracycline-induced pleuritis in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

The urokinase receptor promotes cancer metastasis independently of urokinase-type plasminogen activator in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Intrapleural adenoviral delivery of human plasminogen activator inhibitor-1 exacerbates tetracycline-induced pleural injury in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Redirection of the reaction between activated protein C and a serpin to the substrate pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Mechanisms of conversion of plasminogen activator inhibitor 1 from a suicide inhibitor to a substrate by monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Active α-macroglobulin is a reservoir for urokinase after fibrinolytic therapy in rabbits with tetracycline-induced pleural injury and in human pleural fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Dose dependency of outcomes of intrapleural fibrinolytic therapy in new rabbit empyema models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

The time course of resolution of adhesions during fibrinolytic therapy in tetracycline-induced pleural injury in rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Effects of Extracellular DNA on Plasminogen Activation and Fibrinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Regulation of intrapleural fibrinolysis by urokinase-alpha-macroglobulin complexes in tetracycline-induced pleural injury in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Modulation of serpin reaction through stabilization of transient intermediate by ligands bound to alpha-helix F.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Pleural infection and empyema

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Cytokines and fibrinolytic enzymes in tuberculous and parapneumonic effusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Structural Basis for Recognition of Urokinase-type Plasminogen Activator by Plasminogen Activator Inhibitor-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Amino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

U.K. Controlled trial of intrapleural streptokinase for pleural infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Guidelines for the intravenous application of recombinant tissue-type plasminogen activator (alteplase), the second edition, October 2012: a guideline from the Japan Stroke Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

The influence of fibrin(ogen) fragments on the kinetic parameters of the tissue-type plasminogen-activator-mediated activation of different forms of plasminogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Two sequential tPA/DNase courses for noncommunicating loculated collections in pleural infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Role of Vitronectin and Its Receptors in Haemostasis and Vascular Remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Comparative ultrastructural analyses of mouse, rabbit, and human platelets and fibrin networks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Management of parapneumonic effusions and empyema

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Intrapleural use of tissue plasminogen activator and DNase in pleural infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

On the size of the active site in proteases. I. Papain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Treatment approaches for empyema in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Plasminogen activator inhibitor type 1 derived peptide, EEIIMD, diminishes cortical infarct but fails to improve neurological function in aged rats following middle cerebral artery occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Randomised trial of intrapleural urokinase in the treatment of childhood empyema

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Plasminogen-plasmin system in the pathogenesis and treatment of lung and pleural injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Organizing empyema induced in mice by Streptococcus pneumoniae: effects of plasminogen activator inhibitor-1 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Airway tissue plasminogen activator prevents acute mortality due to lethal sulfur mustard inhalation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Tissue plasminogen activator prevents mortality from sulfur mustard analog-induced airway obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Characterization of a new mouse model of empyema and the mechanisms of pleural invasion by Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Novel or expanding current targets in fibrinolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

Regulation of Single Chain Urokinase Binding, Internalization, and Degradation by a Plasminogen Activator Inhibitor 1-Derived Peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152/AJPLUNG.00579.2016

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise th

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6048456

Increase in incidence of childhood empyema

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6048456

A steady-state template model that describes the kinetics of fibrin-stimulated [Glu1]- and [Lys78]plasminogen activation by native tissue-type plasminogen activator and variants that lack either the finger or kringle-2 domain

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6048456

Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6048456

Selective embolization and clot dissolution with tPA in the internal carotid artery circulation of the rabbit

2 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6048456

Neutralization of plasminogen activator inhibitor-1 inhibitory properties: identification of two different mechanisms

2 November 2018

1 reference

12 December 2020

Plasminogen activator inhibitor 1 (PAI) is bound to vitronectin in plasma

1 reference

12 December 2020

1 reference

12 December 2020

Evaluation of a pediatric protocol of intrapleural urokinase for pleural empyema: a prospective study

1 reference

12 December 2020

Increase in incidence of childhood empyema in West Midlands, UK

1 reference

12 December 2020

Accelerated conversion of human plasminogen activator inhibitor-1 to its latent form by antibody binding

1 reference

12 December 2020

Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2

1 reference

12 December 2020

Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-II

1 reference

12 December 2020

Elucidation of the binding regions of PAI-1 neutralizing antibodies using chimeric variants of human and rat PAI-1

1 reference

12 December 2020

Once-daily intrapleural urokinase treatment of complicated parapneumonic effusion in pediatric patients

1 reference

12 December 2020

Tissue factor pathway inhibitor in tetracycline-induced pleuritis in rabbits

1 reference

12 December 2020

Comparison of a 60- versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction. In TIME-II Investigators. Intravenous nPA for Treatment of Infarcting Myocardium Early-II

1 reference

12 December 2020

Fibrinolytic and inflammatory processes in pleural effusions

1 reference

12 December 2020

The histology of experimental pleural injury with tetracycline, empyema, and carrageenan

1 reference

12 December 2020

Thrombin-antithrombin III complex, proinflammatory cytokines, and fibrinolytic indices for assessing the severity of inflammation in pleural effusions

1 reference

12 December 2020

Additivity in effects of vitronectin and monoclonal antibodies against alpha-helix F of plasminogen activator inhibitor-1 on its reactions with target proteinases

1 reference

12 December 2020

Kinetics of the activation of plasminogen by natural and recombinant tissue-type plasminogen activator

1 reference

12 December 2020

Treatment of complicated pleural effusion with intracavitary urokinase in children

1 reference

12 December 2020

Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions

1 reference

12 December 2020

10.1152/AJPLUNG.00579.2016

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28860148 AND SRC:MED&resulttype=core&format=json

28 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28860148 AND SRC:MED&resulttype=core&format=json

28 March 2020

PubMed publication ID

28860148

1 reference